Vandalay, this is from a press release from 8-22-18
On July 23rd, 2018, CV Sciences submitted its application to list the Company’s common stock in the U.S. on the Nasdaq Capital Market. About CV Sciences, Inc. CV Sciences, Inc. (OTCQB:CVSI) operates two distinct business segments: a drug development division focused on developing and commercializing novel therapeutics utilizing synthetic CBD; and, a consumer product division focused on manufacturing, marketing and selling plant-based CBD products (PlusCBD Oil™) to a range of market sectors. CV Sciences, Inc. has primary offices and facilities in San Diego, California and Las Vegas, Nevada. Additional information is available from OTCMarkets.com or by visiting www.cvsciences.com.
I have a hard time where your statement about January comes from. Please elaborate...
Thank you